Projects per year
Fingerprint The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.
- 3 Similar Profiles
Hemophilia A
Medicine & Life Sciences
Factor VIII
Medicine & Life Sciences
Hemorrhage
Medicine & Life Sciences
Therapeutics
Medicine & Life Sciences
Antibodies
Medicine & Life Sciences
Healthy Volunteers
Medicine & Life Sciences
von Willebrand Diseases
Medicine & Life Sciences
Partial Thromboplastin Time
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 1993 2023
A Phase 3 Open-Label, Single-Arm Study To Evaluate The Efficacy and Safety of BMN 270, an Adeno-Associated Virus Vector Mediated Gene Transfer of Human Factor VIII at a dose of 4E13 vg/kg inHemophilia A Patients with Residual FVIII Levels
7/15/18 → 7/15/23
Project: Research project
Transfer Factor
Dependovirus
Hemophilia A
Safety
Genes
A Phase 3 Open-Label, Single-Arm Study To Evaluate The Efficacy and Safety of BMN 270, an Adeno-Associated Virus Vector-Mediated Gene Transfer of Human Factor VIII in Hemophilia A Patients with Residual FVIII Levels...
5/1/18 → 7/15/23
Project: Research project
Transfer Factor
Dependovirus
Hemophilia A
Safety
Genes
Factor VIII
Hemophilia A
Hemorrhage
Patient Reported Outcome Measures
ECHO: Expanding Communications on Hemophilia-A Outcomes.
BAYER HEALTHCARE PHARMACEUTICALS
7/1/16 → 12/31/21
Project: Research project
Hemophilia A
Registries
Patient Reported Outcome Measures
Public Health Surveillance
Hemorrhage
Research Output 1997 2019
Reversal of acquired von Willebrand syndrome with allogeneic stem cell transplant for chronic lymphocytic leukemia
Hegerova, L., He, F. C., Zantek, N. D., Vercellotti, G. M., Holtan, S. G. & Reding, M. T., Jul 1 2019, In : Blood Cells, Molecules, and Diseases. 77, p. 109-112 4 p.Research output: Contribution to journal › Article
von Willebrand Factor
B-Cell Chronic Lymphocytic Leukemia
Stem Cells
Transplants
Antibodies
1
Citation
(Scopus)
Catheter-Related Thrombosis in Patients with Lymphoma or Myeloma Undergoing Autologous Stem Cell Transplantation
Hegerova, L., Bachan, A., Cao, Q., Vu, H. X., Rogosheske, J., Reding, M. T., Brunstein, C. G., Arora, M., Ustun, C., Vercellotti, G. M. & Bachanova, V., Dec 1 2018, In : Biology of Blood and Marrow Transplantation. 24, 12, p. e20-e25Research output: Contribution to journal › Article
Stem Cell Transplantation
Lymphoma
Thrombosis
Catheters
Cell Transplantation
4
Citations
(Scopus)
Plasma exchange to remove heparin-induced thrombocytopenia antibodies and the use of heparin during cardiopulmonary bypass in critically ill cardiac patients
Ramu, B., Cogswell, R. J., Reding, M. T., John, R. & Martin, C. M., Aug 1 2018, In : Journal of Heart and Lung Transplantation. 37, 8, p. 1038-1040 3 p.Research output: Contribution to journal › Letter
Plasma Exchange
Cardiopulmonary Bypass
Critical Illness
Thrombocytopenia
Heparin
14
Citations
(Scopus)
Effect of late prophylaxis in hemophilia on joint status: a randomized trial
Manco-Johnson, M. J., Lundin, B., Funk, S., Peterfy, C., Raunig, D., Werk, M., Kempton, C. L., Reding, M. T., Goranov, S., Gercheva, L., Rusen, L., Uscatescu, V., Pierdominici, M., Engelen, S., Pocoski, J., Walker, D. & Hong, W., Nov 1 2017, In : Journal of Thrombosis and Haemostasis. 15, 11, p. 2115-2124 10 p.Research output: Contribution to journal › Article
Hemophilia A
Joint Diseases
Joints
Hemorrhage
Least-Squares Analysis
7
Citations
(Scopus)
Efficacy and safety of a VWF/FVIII concentrate (wilate®) in inherited von Willebrand disease patients undergoing surgical procedures
Srivastava, A., Serban, M., Werner, S., Schwartz, B. A., Kessler, C. M., Alkindi, S., Apte, S. J., Castaman, G., Gill, J. C., Hellmann, A., Kavakli, K., Kouides, P. A., Kuriakose, P., Lissitchkov, T., Ma, A., Mahlangu, J., Morfini, M., Neufeld, E. J., Peyvandi, F., Reding, M. & 8 others, , Mar 1 2017, In : Haemophilia. 23, 2, p. 264-272 9 p.Research output: Contribution to journal › Article
von Willebrand Diseases
Type 3 Von Willebrand's Disease
Safety
Hemorrhage
Clinical Trials Data Monitoring Committees